Prevalence of HPV and Type Distribution in Southeast Asian Women Residing in Rhode Island

Objective: The objective of this study was to assess the prevalence of cervical high-risk HPV among Southeast Asian women and describe the distribution of the high-risk genotypes. Methods: SE Asian women (n=57) ages 18 years and older and residing in and around the vicinity of Providence, RI were enrolled. Women were recruited at community health centers and underwent thin-prep pap smears and high-risk HPV genotyping of the cervix. All pap smears were reviewed at Women & Infants Hospital of Rhode Island by specialized gynecologic cytopathologists, and thin prep vials sent for HPV genotyping. Results: The median age of SE Asian participants was 38 years old (range 21-63). Fifteen (26%) were married and the majority were born outside of the United States. The majority had sexual partners born outside the US (60%). High-risk HPV was detected in 14 (25.0%) women with the most common genotypes being 51 (28.6%), 52 (21.4%), 56 (21.4%), and 59 (21.4%). Of interest, HPV 16 was only reported in one woman; none had HPV 18. Co-infection with more than one HPV genotype was seen in 6 (10.7 %) women. Conclusions: High-risk HPV is prevalent even among low risk SE Asian women residing in the north-east. However, HPV 16 was rarely identified and none of this cohort had evidence of HPV18 infection. These data demonstrate that HPV vaccination must take into account the heterogeneity of infections among different racial groups to aid in future vaccine development.

[1]  L. Downs,et al.  Cervical cytology and multiple type HPV infection: a study of 8182 women ages 31-65. , 2014, Gynecologic oncology.

[2]  M. Clark,et al.  Cervical cancer prevention: Asian-American women's knowledge and participation in screening practices. , 2014, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[3]  T. Sasagawa,et al.  E6 and E7 variants of human papillomavirus‐16 and ‐52 in Japan, the Philippines, and Vietnam , 2013, Journal of medical virology.

[4]  Robert N. Anderson,et al.  Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels , 2013, Journal of the National Cancer Institute.

[5]  Lan Vu,et al.  Prevalence of cervical infection with HPV type 16 and 18 in Vietnam: implications for vaccine campaign , 2013, BMC Cancer.

[6]  H. Pham,et al.  Infection with high‐risk HPV types among female sex workers in northern Vietnam , 2013, Journal of medical virology.

[7]  S. Garland,et al.  A review of clinical trials of human papillomavirus prophylactic vaccines. , 2012, Vaccine.

[8]  C. Saenz,et al.  Changing demographics of cervical cancer in the United States (1973-2008). , 2012, Gynecologic oncology.

[9]  Deepa Naishadham,et al.  Cancer statistics for Hispanics/Latinos, 2012 , 2012, CA: a cancer journal for clinicians.

[10]  Lisa Maher,et al.  Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection , 2012, BMC Infectious Diseases.

[11]  Y. Yasui,et al.  HPV Vaccination Uptake Among Cambodian Mothers , 2012, Journal of Cancer Education.

[12]  E. Unger,et al.  Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States--National Health And Nutrition Examination Survey, 2003-2006: opportunity to measure HPV vaccine impact? , 2011, The Journal of infectious diseases.

[13]  E. Unger,et al.  Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. , 2011, The Journal of infectious diseases.

[14]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[15]  R. DeSalle,et al.  A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. , 2010, Cancer research.

[16]  P. Bonanni,et al.  Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence. , 2009, Vaccine.

[17]  Y. Qiao,et al.  A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination. , 2008, Vaccine.

[18]  K. Chu,et al.  Cambodian cancer incidence rates in California and Washington, 1998–2002 , 2007, Cancer.

[19]  Moon S. Chen,et al.  Cancer Incidence, Mortality, and Associated Risk Factors Among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese Ethnicities , 2007, CA: a cancer journal for clinicians.

[20]  Daron G Ferris,et al.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. , 2007, The New England journal of medicine.

[21]  H. Trottier,et al.  Human Papillomavirus Infections with Multiple Types and Risk of Cervical Neoplasia , 2006, Cancer Epidemiology Biomarkers & Prevention.

[22]  Israel De Alba,et al.  Pap smear use in California: are we closing the racial/ethnic gap? , 2005, Preventive medicine.

[23]  Tung T. Nguyen,et al.  Human Papillomavirus and Abnormal Pap Test Results in Vietnamese-American Women: A Pilot Case-Control Study , 2004, Journal of lower genital tract disease.

[24]  C J L M Meijer,et al.  The causal relation between human papillomavirus and cervical cancer. , 2002, Journal of clinical pathology.